Skip to main content

Advertisement

Log in

“Rationalization of Empiric Antibiotic Therapy” – A Move Towards Preventing Emergence of Resistant Infections

  • Review Article
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Antimicrobial resistance is a key factor leading to emerging/ re-emerging infections. Rational antimicrobial therapy or antimicrobial stewardship is one of the important interventions to prevent emergence of resistance. Choosing correct empiric therapy is crucial not only to prevent antimicrobial resistance but also to achieve good treatment outcomes. Antimicrobial therapy can be broadly classified as empiric, definitive/ targeted and preventive. It is in choice of empiric therapy that the largest margin of error exists. Paradoxically, empiric therapy is the most commonly employed therapy since microbiologic results are either not available at initiation of treatment or cannot be sent due to logistic reasons or are negative. In the Indian setting, where penetration of microbiologic diagnostic methods in small cities, towns and rural areas is still fairly low, therapy is largely empiric. Choice of empiric therapy is governed by various factors including likely pathogens, antimicrobial resistance, degree of sickness, site of infection and host co-morbidities. These principles can be applied to any clinical syndrome whether it is fever without focus, infections of the respiratory tract, gastrointestinal tract, abdomen, central nervous system, bone and joint, skin and soft tissue, urinary tract as well as neonatal sepsis and healthcare associated infections. Adherence to published guidelines for syndromic management such as that by the Indian Academy of Pediatrics and Indian Council of Medical Research is strongly recommended. One can tailor these guidelines and suggestions made in this article to an individual setting.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Dikid T, Jain SK, Sharma A, Kumar A, Narain JP. Emerging & re-emerging infections in India: an overview. Indian J Med Res. 2013;138:19–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Interagency Coordination Group on Antimicrobial Resistance. No time to wait: Securing the future from drug resistant infections. Report to the Secretary General of the United Nations April 2019. Available at: https://www.who.int/antimicrobial-resistance/interagency-coordination-group/IACG_final_summary_EN.pdf?ua=1. Accessed 28 October 2019.

  3. Veeraraghavan B, Walia K. Antimicrobial susceptibility profile & resistance mechanisms of global antimicrobial resistance surveillance system (GLASS) priority pathogens from India. Indian J Med Res. 2019;149:87–96.

    Article  CAS  Google Scholar 

  4. Shulman ST, Bisno AL, Clegg HW, et al; Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group a streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis. 2012;55:e86–102.

    Article  Google Scholar 

  5. Paisley JW, Lauer BA. Pediatric blood cultures. Clin Lab Med. 1994;14:17–30.

    Article  CAS  Google Scholar 

  6. Verghese VP, Veeraraghavan B, Jayaraman R, et al. Increasing incidence of penicillin- and cefotaxime-resistant Streptococcus pneumoniae causing meningitis in India: time for revision of treatment guidelines? Indian J Med Microbiol. 2017;35:228–36.

    Article  Google Scholar 

  7. Indian Council of Medical Research. Treatment guidelines for antimicrobial use in common syndromes 2019. Available at: https://www.icmr.nic.in/sites/default/files/guidelines/Treatment_Guidelines_2019_Final.pdf. Accessed 28 October 2019

  8. Tsuji BT, Pogue JM, Zavascki AP, et al. International consensus guidelines for the optimal use of the polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy. 2019;39:10–39.

    Article  Google Scholar 

  9. Onakpoya IJ, Walker AS, Tan PS, et al. Overview of systematic reviews assessing the evidence for shorter versus longer duration antibiotic treatment for bacterial infections in secondary care. PLoS One. 2018;13:e0194858.

    Article  Google Scholar 

  10. Woll C, Neuman MI, Aronson PL. Management of the febrile young infant: update for the 21st century. Pediatr Emerg Care. 2017;33:748–53.

    Article  Google Scholar 

  11. Singhi S, Chaudhary D, Varghese GM, et al; The Indian Society of Critical Care Medicine Tropical Fever Group. Tropical fevers: management guidelines. Indian J Crit Care Med. 2014;18:62–9.

    Article  Google Scholar 

  12. Abraham MK, Perkins J, Vilke GM, Coyne CJ. Influenza in the emergency department: vaccination, diagnosis, and treatment: clinical practice paper approved by American Academy of Emergency Medicine Clinical Guidelines Committee. J Emerg Med. 2016;50:536–42.

    Article  Google Scholar 

  13. Gupta S, Lodha R, Kabra SK. Antimicrobial therapy in community-acquired pneumonia in children. Curr Infect Dis Rep. 2018;20:47.

    Article  Google Scholar 

  14. Stevens DL, Bisno AL, Chambers HF, et al; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–52.

    Article  Google Scholar 

  15. Wong JW, Ip M, Tang A, et al. Prevalence and risk factors of community-associated methicillin-resistant Staphylococcus aureus carriage in Asia-Pacific region from 2000 to 2016: a systematic review and meta-analysis. Clin Epidemiol. 2018;10:1489–501.

    Article  Google Scholar 

  16. Gutierrez K. Bone and joint infections in children. Pediatr Clin N Am. 2005;52:779–94.

    Article  Google Scholar 

  17. Balasubramanian S, Kuppuswamy D, Padmanabhan S, Chandramohan V, Amperayani S. Extended-spectrum beta-lactamase-producing community-acquired urinary tract infections in children: chart review of risk factors. J Glob Infect Dis. 2018;10:222–5.

    Article  CAS  Google Scholar 

  18. Indian Society of Pediatric Nephrology. Revised statement on management of urinary tract infections. Indian Pediatr. 2011;48:709–17.

    Google Scholar 

  19. Sharma S, Mishra D, Aneja S, Kumar R, Jain A, Vashishtha VM; Expert group on encephalitis, Indian Academy of Pediatrics. Consensus guidelines on evaluation and management of suspected acute viral encephalitis in children in India. Indian Pediatr. 2012;49:897–910.

    Article  Google Scholar 

  20. Solomkin JS, Mazuski JE, Bradley JS, et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the surgical infection society and the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:133–64.

    Article  Google Scholar 

  21. National Neonatal Perinatal Database: Report 2002–2003. New Delhi: ICMR; 2005. p. 45–57.

    Google Scholar 

  22. Jajoo M, Manchanda V, Chaurasia S, et al; Investigators of the Delhi Neonatal Infection Study (DeNIS) collaboration, New Delhi, India. Alarming rates of antimicrobial resistance and fungal sepsis in outborn neonates in North India. PLoS One. 2018;13:e0180705.

    Article  Google Scholar 

  23. Singhal T. Antimicrobial therapy in health care associated infections. In: Singhal T, Shah N, Prabhu S, Yewale VN, editors. Rational Anti Microbial Therapy in Paediatrics. New Delhi: Jaypee Brothers; 2019. p. 322–30.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tanu Singhal.

Ethics declarations

Conflict of Interest

None.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singhal, T. “Rationalization of Empiric Antibiotic Therapy” – A Move Towards Preventing Emergence of Resistant Infections. Indian J Pediatr 87, 945–950 (2020). https://doi.org/10.1007/s12098-019-03144-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-019-03144-7

Keywords

Navigation